These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25125020)

  • 1. Chronic obstructive pulmonary disease and hypertrophic obstructive cardiomyopathy: two antagonistic obstructions.
    Siniorakis E; Arvanitakis S; Pavlouros T; Batila T; Ntanos I; Rentoukas E
    Int J Cardiol; 2014 Oct; 176(3):e129-30. PubMed ID: 25125020
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular collapse in a 77-year-old-woman with an asthma exacerbation following bronchodilator treatment.
    Meyer MF; Hopkins WE; Kaminsky DA
    Chest; 2003 Sep; 124(3):1160-3. PubMed ID: 12970051
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemorrhagic bullae with nebulised ipratropium bromide.
    Saravanan V; Bankar RN; Kumar S; Williams JG
    J Postgrad Med; 2006; 52(3):235-6. PubMed ID: 16855336
    [No Abstract]   [Full Text] [Related]  

  • 4. Transient anisocoria caused by aerosolized ipratropium bromide exposure from an ill-fitting face mask.
    Wehbe E; Antoun SA; Moussa J; Nassif I
    J Neuroophthalmol; 2008 Sep; 28(3):236-7. PubMed ID: 18769293
    [No Abstract]   [Full Text] [Related]  

  • 5. Stress-induced cardiomyopathy associated with ipratropium bromide therapy in a patient with chronic obstructive pulmonary disease.
    Melão F; Nunes JP; Vasconcelos M; Dias P; Almeida PB; Rodrigues R; Pinho T; Madureira A; Maciel MJ
    Rev Port Cardiol; 2014 Mar; 33(3):175.e1-4. PubMed ID: 24680554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertensive heart disease and bronchodilators: Potential left ventricular outflow obstruction.
    Siniorakis E; Arvanitakis S; Tzevelekos P; Panta S; Zampelis C; Aivalioti F; Rentoukas E
    Int J Cardiol; 2015 Oct; 196():123-4. PubMed ID: 26093159
    [No Abstract]   [Full Text] [Related]  

  • 7. Dry powder ipratropium bromide is as safe and effective as metered-dose inhaler formulation: a cumulative dose-response study in chronic obstructive pulmonary disease patients.
    Cuvelier A; Muir JF; Benhamou D; Weitzenblum E; Zuck P; Delacenserie R; Taytard A; Iacono P
    Respir Care; 2002 Feb; 47(2):159-66. PubMed ID: 11812272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nebulized bronchodilators and left ventricular outflow obstruction.
    Siniorakis E; Arvanitakis S; Rentoukas E
    Int J Cardiol; 2016 Jan; 203():1140. PubMed ID: 26620703
    [No Abstract]   [Full Text] [Related]  

  • 9. [What dosage is sufficient in combined inhalation therapy (fenoterol + ipratropium bromide) in patients with exacerbation of chronic obstructive lung disease?].
    Musil J; Hirsch V; Vondra V; Reisová M
    Vnitr Lek; 1998 Jul; 44(7):415-7. PubMed ID: 9748878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there any association between inhaled ipratropium and mortality in patients with COPD and asthma?
    Ringbaek T; Viskum K
    Respir Med; 2003 Mar; 97(3):264-72. PubMed ID: 12645834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral disopyramide for the acute treatment of severe outflow obstruction in hypertrophic cardiomyopathy in the ICU setting.
    Sirak TE; Sherrid MV
    Chest; 2008 May; 133(5):1243-6. PubMed ID: 18460523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease.
    Dahl R; Greefhorst LA; Nowak D; Nonikov V; Byrne AM; Thomson MH; Till D; Della Cioppa G;
    Am J Respir Crit Care Med; 2001 Sep; 164(5):778-84. PubMed ID: 11549532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of parasympatholytic and sympatheticomimetic nebulization therapy in gradient increase in the left ventricular outflow tract: Do they have the same influence?
    Kırat T; Köse N; Altun İ; Akın F; Soylu MÖ
    Int J Cardiol; 2016 Jan; 203():1138-9. PubMed ID: 26515255
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparison of tiotropium inhalation capsules and ipratropium metered dose inhaler in a randomized, double-blind, double-dummy, efficacy and safety study in patients with chronic obstructive pulmonary disease].
    Zheng JP; Kang J; Cai BQ; Zhou X; Cao ZL; Bai CX; Zhong NS
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jun; 29(6):363-7. PubMed ID: 17045014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled formoterol versus ipratropium bromide in chronic obstructive pulmonary disease.
    Chhabra SK; Vijayan VK; Vasu T
    Indian J Chest Dis Allied Sci; 2006; 48(2):97-102. PubMed ID: 16696522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: an eight-week, multicenter, randomized, double-blind, double-dummy, parallel-group study.
    Make B; Hanania NA; ZuWallack R; Kalberg C; Emmett A; Brown CP; Knobil K
    Clin Ther; 2005 May; 27(5):531-42. PubMed ID: 15978302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of single inhalation of a salbutamol, ipratropium bromide and beclomethasone on mucociliary clearance in patients with chronic obstructive airway disease.
    Guleria R; Singh TR; Sinha S; Padhy K; Gupta K; Pande JN
    Indian J Chest Dis Allied Sci; 2003; 45(4):241-6. PubMed ID: 12962458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Unilateral mydriasis of pharmacological origin].
    Martín Guerra JM; Iglesias Pérez C; Martín Asenjo M; Rodríguez Fernández L
    Rev Esp Geriatr Gerontol; 2019; 54(6):360. PubMed ID: 30598303
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacologic unilateral mydriasis due to nebulized ipratropium bromide.
    Camkurt MA; Ay D; Akkucuk H; Ozcan H; Kunt MM
    Am J Emerg Med; 2011 Jun; 29(5):576.e5-6. PubMed ID: 20708871
    [No Abstract]   [Full Text] [Related]  

  • 20. A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary disease.
    Balkissoon R; Make B
    COPD; 2008 Aug; 5(4):221-7. PubMed ID: 18671147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.